Home › NDC Lookup › RxCUI directory › RxCUI 359385

24 HR clarithromycin 500 MG Extended Release Oral Tablet — RxCUI 359385

RxNorm drug concept · Semantic clinical drug
RxCUI 359385 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI359385
Official name24 HR clarithromycin 500 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asclarithromycin 500 MG 24HR Extended Release Oral Tablet
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)364 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Clarithromycin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Clarithromycin is used for a range of bacterial infections — things like community-acquired pneumonia, sinus infections, flare-ups of chronic bronchitis, strep throat, skin infecti...
  • What kind of infections does clarithromycin treat?
  • It depends on which form you have. Regular clarithromycin tablets can be taken with or without food — your stomach contents don't affect how much of the drug gets absorbed. However...
  • Do I need to take clarithromycin with food?
📖 Read our full Clarithromycin guide →

🕸️ Concept Web — How 24 HR clarithromycin 500 MG Extended Release Ora... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR clarithromycin 500 MG Extended Release Oral Tablet RxCUI 359385

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Clarithromycin 21212
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Clarithromycin Extended Release Oral Tablet 371541
    • Clarithromycin Oral Product 1152762
    • Clarithromycin Pill 1152763
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Clarithromycin 500 MG 315695

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Clarithromycin 500 MG SCDC · 315695
  • Clarithromycin Extended Release Oral Tablet SCDF · 371541
  • Clarithromycin Oral Product SCDG · 1152762
  • Clarithromycin Pill SCDG · 1152763

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 359385 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00527-1930-06 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0527-1... Clarithromycin Lannett Company, Inc. 2019-09-10
00591-2805-60 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... clarithromycin Actavis Pharma, Inc. 2014-02-27
43063-0942-14 14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... Clarithromycin PD-Rx Pharmaceuticals, Inc. 2019-09-10
62135-0883-60 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62135-... CLARITHROMYCIN Chartwell RX, LLC 2024-04-16
73473-0911-60 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (73473-... Clarithromycin Solaris Pharma Corporation 2019-09-10
Observed labelers: Actavis Pharma, Inc. (1) · Chartwell RX, LLC (1) · Lannett Company, Inc. (1) · PD-Rx Pharmaceuticals, Inc. (1) · Solaris Pharma Corporation (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$2.6264
Range $2.6264–$2.6264 · middle 50% $2.6264–$2.6264 · 4 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.